Prediction of IL4 inducing peptides
- PMID: 24489573
- PMCID: PMC3893860
- DOI: 10.1155/2013/263952
Prediction of IL4 inducing peptides
Abstract
The secretion of Interleukin-4 (IL4) is the characteristic of T-helper 2 responses. IL4 is a cytokine produced by CD4+ T cells in response to helminthes and other extracellular parasites. It has a critical role in guiding antibody class switching, hematopoiesis and inflammation, and the development of appropriate effector T-cell responses. In this study, it is the first time an attempt has been made to understand whether it is possible to predict IL4 inducing peptides. The data set used in this study comprises 904 experimentally validated IL4 inducing and 742 noninducing MHC class II binders. Our analysis revealed that certain types of residues are preferred at certain positions in IL4 inducing peptides. It was also observed that IL4 inducing and noninducing epitopes differ in compositional and motif pattern. Based on our analysis we developed classification models where the hybrid method of amino acid pairs and motif information performed the best with maximum accuracy of 75.76% and MCC of 0.51. These results indicate that it is possible to predict IL4 inducing peptides with reasonable precession. These models would be useful in designing the peptides that may induce desired Th2 response.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3893860/bin/CDI2013-263952.001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3893860/bin/CDI2013-263952.002.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3893860/bin/CDI2013-263952.003.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3893860/bin/CDI2013-263952.004.gif)
Similar articles
-
Prediction and analysis of promiscuous T cell-epitopes derived from the vaccine candidate antigens of Leishmania donovani binding to MHC class-II alleles using in silico approach.Infect Genet Evol. 2017 Sep;53:107-115. doi: 10.1016/j.meegid.2017.05.022. Epub 2017 May 23. Infect Genet Evol. 2017. PMID: 28549876
-
Designing of interferon-gamma inducing MHC class-II binders.Biol Direct. 2013 Dec 5;8:30. doi: 10.1186/1745-6150-8-30. Biol Direct. 2013. PMID: 24304645 Free PMC article.
-
MHC class II epitope predictive algorithms.Immunology. 2010 Jul;130(3):319-28. doi: 10.1111/j.1365-2567.2010.03268.x. Epub 2010 Apr 12. Immunology. 2010. PMID: 20408898 Free PMC article. Review.
-
Recognition of core and flanking amino acids of MHC class II-bound peptides by the T cell receptor.Eur J Immunol. 2002 Sep;32(9):2510-20. doi: 10.1002/1521-4141(200209)32:9<2510::AID-IMMU2510>3.0.CO;2-Q. Eur J Immunol. 2002. PMID: 12207335
-
MHC molecules as peptide receptors.Curr Opin Immunol. 1993 Feb;5(1):35-44. doi: 10.1016/0952-7915(93)90078-7. Curr Opin Immunol. 1993. PMID: 7680871 Review.
Cited by
-
Development of multi-epitope mRNA vaccine against Clostridioides difficile using reverse vaccinology and immunoinformatics approaches.Synth Syst Biotechnol. 2024 May 18;9(4):667-683. doi: 10.1016/j.synbio.2024.05.008. eCollection 2024 Dec. Synth Syst Biotechnol. 2024. PMID: 38817826 Free PMC article.
-
Computer-aided designing of a novel multi‑epitope DNA vaccine against severe fever with thrombocytopenia syndrome virus.BMC Infect Dis. 2024 May 7;24(1):476. doi: 10.1186/s12879-024-09361-6. BMC Infect Dis. 2024. PMID: 38714948 Free PMC article.
-
Integrating immunoinformatics and computational epitope prediction for a vaccine candidate against respiratory syncytial virus.Infect Dis Model. 2024 Apr 16;9(3):763-774. doi: 10.1016/j.idm.2024.04.005. eCollection 2024 Sep. Infect Dis Model. 2024. PMID: 38708060 Free PMC article.
-
Designing a Novel Multiepitope Vaccine from the Human Papilloma Virus E1 and E2 Proteins for Indonesia with Immunoinformatics and Molecular Dynamics Approaches.ACS Omega. 2024 Mar 27;9(14):16547-16562. doi: 10.1021/acsomega.4c00425. eCollection 2024 Apr 9. ACS Omega. 2024. PMID: 38617694 Free PMC article.
-
Discovering peptides and computational investigations of a multiepitope vaccine target Mycobacterium tuberculosis.Synth Syst Biotechnol. 2024 Mar 21;9(3):391-405. doi: 10.1016/j.synbio.2024.03.010. eCollection 2024 Sep. Synth Syst Biotechnol. 2024. PMID: 38585591 Free PMC article.
References
-
- Brown MA, Hural J. Functions of IL-4 and control of its expression. Critical Reviews in Immunology. 1997;17(1):1–32. - PubMed
-
- Röcken M, Racke M, Shevach EM. IL-4-induced immune deviation as antigen-specific therapy for inflammatory autoimmune disease. Immunology Today. 1996;17(5):225–231. - PubMed
-
- Kajiwara A, Doi H, Eguchi J, et al. Interleukin-4 and CpG oligonucleotide therapy suppresses the outgrowth of tumors by activating tumor-specific Th1-type immune responses. Oncology Reports. 2012;27(6):1765–1771. - PubMed
-
- Ghoreschi K, Thomas P, Breit S, et al. Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease. Nature Medicine. 2003;9(1):40–46. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials